283 related articles for article (PubMed ID: 30274973)
21. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract][Full Text] [Related]
22. Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
Ohmoto A; Morizane C; Kubo E; Takai E; Hosoi H; Sakamoto Y; Kondo S; Ueno H; Shimada K; Yachida S; Okusaka T
J Gastroenterol; 2018 Oct; 53(10):1159-1167. PubMed ID: 29667044
[TBL] [Abstract][Full Text] [Related]
23. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.
Real FX; Malats N; Lesca G; Porta M; Chopin S; Lenoir GM; Sinilnikova O;
Gut; 2002 May; 50(5):653-7. PubMed ID: 11950811
[TBL] [Abstract][Full Text] [Related]
24. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Shindo K; Yu J; Suenaga M; Fesharakizadeh S; Cho C; Macgregor-Das A; Siddiqui A; Witmer PD; Tamura K; Song TJ; Navarro Almario JA; Brant A; Borges M; Ford M; Barkley T; He J; Weiss MJ; Wolfgang CL; Roberts NJ; Hruban RH; Klein AP; Goggins M
J Clin Oncol; 2017 Oct; 35(30):3382-3390. PubMed ID: 28767289
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants.
Power R; Leavy C; Nolan C; White N; Clarke R; Cadoo KA; Gallagher DJ; Lowery MA
Fam Cancer; 2021 Apr; 20(2):97-101. PubMed ID: 32918181
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
[TBL] [Abstract][Full Text] [Related]
27. Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma?
Roch AM; Schneider J; Carr RA; Lancaster WP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
J Surg Oncol; 2019 May; 119(6):777-783. PubMed ID: 30636051
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
Ryu KH; Park S; Chun JW; Cho E; Choi J; Lee DE; Shim H; Kim YH; Han SS; Park SJ; Woo SM; Kong SY
Cancer Res Treat; 2023 Oct; 55(4):1303-1312. PubMed ID: 37024097
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic Features and Germline Sequence Variants in Young Patients (≤40 Years Old) With Pancreatic Ductal Adenocarcinoma.
Ohmoto A; Yachida S; Kubo E; Takai E; Suzuki M; Shimada K; Okusaka T; Morizane C
Pancreas; 2016 Aug; 45(7):1056-61. PubMed ID: 26692440
[TBL] [Abstract][Full Text] [Related]
30. Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?
Jordan EJ; Lowery MA; Basturk O; Allen PJ; Yu KH; Tabar V; Beal K; Reidy DL; Yamada Y; Janjigian Y; Abou-Alfa GK; O'Reilly EM
Clin Colorectal Cancer; 2018 Jun; 17(2):e315-e321. PubMed ID: 29496399
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers.
de Mestier L; Danset JB; Neuzillet C; Rebours V; Cros J; Soufir N; Hammel P
Endocr Relat Cancer; 2016 Oct; 23(10):T57-67. PubMed ID: 27511924
[TBL] [Abstract][Full Text] [Related]
34. Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
Golan T; Kanji ZS; Epelbaum R; Devaud N; Dagan E; Holter S; Aderka D; Paluch-Shimon S; Kaufman B; Gershoni-Baruch R; Hedley D; Moore MJ; Friedman E; Gallinger S
Br J Cancer; 2014 Sep; 111(6):1132-8. PubMed ID: 25072261
[TBL] [Abstract][Full Text] [Related]
35. Hereditary vs Familial Pancreatic Cancer: Associated Genetic Syndromes and Clinical Perspective.
Copur MS; Talmon GA; Wedel W; Hart JD; Merani S; Vargasi LM
Oncology (Williston Park); 2020 Jun; 34(6):196-201. PubMed ID: 32609864
[TBL] [Abstract][Full Text] [Related]
36. The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
Laish I; Schechter M; Dancour A; Lieberman S; Levi Z; Goldberg Y; Kedar I; Hasnis E; Half E; Levi GR; Katz L; Vainer ED; Genzel D; Aharoni M; Chen-Shtoyerman R; Abu-Freha N; Raitses-Gurevich M; Golan T; Bernstein-Molho R; Ben Yehoyada M; Gluck N; Rosner G
Cancer; 2024 Jan; 130(2):256-266. PubMed ID: 37861363
[TBL] [Abstract][Full Text] [Related]
37. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
38. Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer.
Goldstein JB; Zhao L; Wang X; Ghelman Y; Overman MJ; Javle MM; Shroff RT; Varadhachary GR; Wolff RA; McAllister F; Futreal A; Fogelman DR
Clin Cancer Res; 2020 Mar; 26(6):1385-1394. PubMed ID: 31871297
[TBL] [Abstract][Full Text] [Related]
39. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.
Frank TS; Deffenbaugh AM; Hulick M; Gumpper K
Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259
[TBL] [Abstract][Full Text] [Related]
40. Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment.
Peters ML; Tseng JF; Miksad RA
Clin Ther; 2016 Jul; 38(7):1622-35. PubMed ID: 27041411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]